股本结构
单位：万股
| 公告日期 | 2024-03-21 | 2024-03-15 | 2024-01-17 | 2024-03-15 | 2023-11-01 | 2023-11-09 |
|---|---|---|---|---|---|---|
| 证券总股本 | 508.94 | 508.94 | 168.46 | 151.76 | 151.76 | 136.76 |
| 普通股本 | 508.94 | 508.94 | 168.46 | 151.76 | 151.76 | 136.76 |
| 优先股 | 0.48 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-18 | 2024-02-22 | 2024-01-10 | 2023-12-31 | 2023-11-02 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-21 | 508.94 | 0.48 | 定期报告 | 2024-03-18 |
| 2024-03-15 | 508.94 | 未披露 | 定期报告 | 2024-02-22 |
| 2024-01-17 | 168.46 | 未披露 | 定期报告 | 2024-01-10 |
| 2024-03-15 | 151.76 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of shares in reverse stock split (for fractional shares)
Issuance of common stock and warrants, under registered public offering
Issuance of shares for vested restricted stock units
|
2023-12-31 |
| 2023-11-01 | 151.76 | 未披露 |
更多>>
Securities offered 150,000 shares by the company
|
2023-11-02 |
| 2023-11-09 | 136.76 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of shares in reverse stock split (for fractional shares)
|
2023-09-30 |
| 2023-08-11 | 136.76 | 未披露 | 定期报告 | 2023-08-09 |
| 2023-07-03 | 133.50 | 未披露 |
更多>>
Biofrontera Inc. announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20 that will become effective after the close of trading at 11:59 p.m. July 3, 2023.
|
2023-07-05 |
| 2023-03-13 | 2669.90 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of pre-funded warrants
Exercise of PIPE warrants
Issuance of common stock and warrants under private placement, net of negligible issuance costs
Issuance of shares for vested restricted stock units
Issuance of common stock in exchange for investments in equity securities
|
2022-12-31 |
| 2022-11-15 | 2669.90 | 未披露 | 定期报告 | 2022-11-02 |
| 2022-11-14 | 2355.10 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of pre-funded warrants
Exercise of PIPE warrants
Issuance of shares for vested restricted stock units
|
2022-09-30 |
| 2022-08-12 | 2355.10 | 未披露 | 定期报告 | 2022-08-11 |
| 2022-08-12 | 1901.14 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock and warrants under private placement, net of issuance costs
Issuance of shares for vested restricted stock units
|
2022-06-30 |
| 2022-06-07 | 1895.47 | 未披露 | 定期报告 | 2022-06-06 |
| 2022-05-13 | 1710.47 | 未披露 | 定期报告 | 2022-03-31 |
| 2021-12-29 | 1710.47 | 未披露 | 定期报告 | 2021-12-28 |
| 2021-12-23 | 1505.60 | 未披露 | 定期报告 | 2021-12-20 |
| 2021-11-03 | 1214.00 | 未披露 |
更多>>
1.The underwriters exercised in full their option to purchase up to an additional 540,000 Warrants to cover over-allotments.
2.The number of shares of common stock to be outstanding after this offering is based on 11,600,000 shares of common stock outstanding as of October 29, 2021
|
2021-11-02 |
| 2021-11-01 | 1160.00 | 未披露 |
更多>>
1.Securities offered by company 3,600,000 units.
2.The number of shares of common stock to be outstanding after this offering is based on 8,000,000 shares of common stock outstanding as of June 30, 2021
|
2021-10-29 |
From December 31, 2022 to December 31, 2023
Issuance of shares in reverse stock split (for fractional shares)
Issuance of common stock and warrants, under registered public offering
Issuance of shares for vested restricted stock units
Securities offered 150,000 shares by the company
From June 30, 2023 to September 30, 2023
Issuance of shares in reverse stock split (for fractional shares)
Biofrontera Inc. announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20 that will become effective after the close of trading at 11:59 p.m. July 3, 2023.
From December 31, 2021 to December 31, 2022
Exercise of pre-funded warrants
Exercise of PIPE warrants
Issuance of common stock and warrants under private placement, net of negligible issuance costs
Issuance of shares for vested restricted stock units
Issuance of common stock in exchange for investments in equity securities
From June 30, 2022 to September 30, 2022
Exercise of pre-funded warrants
Exercise of PIPE warrants
Issuance of shares for vested restricted stock units
From March 31, 2022 to June 30, 2022
Issuance of common stock and warrants under private placement, net of issuance costs
Issuance of shares for vested restricted stock units
1.The underwriters exercised in full their option to purchase up to an additional 540,000 Warrants to cover over-allotments.
2.The number of shares of common stock to be outstanding after this offering is based on 11,600,000 shares of common stock outstanding as of October 29, 2021
1.Securities offered by company 3,600,000 units.
2.The number of shares of common stock to be outstanding after this offering is based on 8,000,000 shares of common stock outstanding as of June 30, 2021